Abiopharma

New Form 144/A - Fulgent Genetics, Inc. Filed: 2025-08-27 AccNo: 0001819718-25-000015 Size: 6 KB

New Form 144/A - Fulgent Genetics, Inc. Filed: 2025-08-27 AccNo: 0001819718-25-000016 Size: 6 KB

Ryan Jason 🔴 sold 39.2K shares of GeneDx Holdings Corp. (WGS) at $130.01 ($5.0M) Transaction Date: Aug 27, 2025 | Filing ID: 023190

Dizon Romeo R 🟢 acquired 1.0K shares of IRIDEX CORP (IRIX) at $1.30 Transaction Date: Aug 27, 2025 | Filing ID: 111774

Bjork Elisabeth 🟢 acquired 10.0K shares of ROCKET PHARMACEUTICALS, INC. (RCKT) at $3.41 Transaction Date: Aug 27, 2025 | Filing ID: 033017

Cognition Therapeutics Announces $30 Million Registered Direct Offering of Common Stock

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: ModivCare Inc. - Common Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: ModivCare Inc. - Common Stock. New value: ModivCare Inc. - Common Stock.

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: ModivCare Inc. - Common Stock.

Reshaping operational efficiency with VR and AR technology

IMVT Investors Have Opportunity to Join Immunovant, Inc. Fraud Investigation with the Schall Law Firm

New Form 144 - Fulgent Genetics, Inc. Filed: 2025-08-27 AccNo: 0001819718-25-000012 Size: 7 KB

New Form 144 - Fulgent Genetics, Inc. Filed: 2025-08-27 AccNo: 0001684532-25-000008 Size: 7 KB

General Announcement: Request for Lifting of Trading Halt - Sponsors Statement

Request for Lifting of Trading Halt: Request for Lifting of Trading Halt